Showing results (1-10 of 530) with videos related to
Sort By:
Pageof 53
Rapid Communications in Mass Spectrometry : RCM|September 13, 2005
Improved sensitivity for quantification of proteins using triply charged cleavable isotope-coded affinity tag peptidesJun Qu, Robert M StraubingerAnalytical Chemistry|April 7, 2007
Ultra-sensitive quantification of corticosteroids in plasma samples using selective solid-phase extraction and reversed-phase capillary high-performance liquid chromatography/tandem mass spectrometryJun Qu, Yang Qu, Robert M StraubingerAnalytical Chemistry|July 1, 2006
Utility of cleavable isotope-coded affinity-tagged reagents for quantification of low-copy proteins induced by methylprednisolone using liquid chromatography/tandem mass spectrometryJun Qu, William J Jusko, Robert M StraubingerAnticancer Research|June 28, 2007
Applications of quantitative pharmacodynamic effect markers in drug target identification and therapy developmentRobert M Straubinger, Wojciech Krzyzanski, Crystal M Francoforte, et al.Journal of Chromatography. A|October 7, 2008
Ultra-sensitive quantification of paclitaxel using selective solid-phase extraction in conjunction with reversed-phase capillary liquid chromatography/tandem mass spectrometryHaoying Yu, Robert M Straubinger, Jin Cao, et al.Journal of Proteome Research|October 31, 2023
Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis PathwaySailee Rasam, Qingxiang Lin, Shichen Shen, et al.The Analyst|December 17, 2008
Highly selective and sensitive assay for paclitaxel accumulation by tumor cells based on selective solid phase extraction and micro-flow liquid chromatography coupled to mass spectrometryJulio R Gaspar, Jun Qu, Ninfa L Straubinger, et al.BMC Cancer|October 24, 2020
Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cellsJin Niu, Xue Wang, Jun Qu, et al.Frontiers in Pharmacology|March 10, 2018
Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer CellsXu Zhu, Xiaomeng Shen, Jun Qu, et al.CPT: Pharmacometrics & Systems Pharmacology|August 8, 2018
Multi-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer CellsXu Zhu, Xiaomeng Shen, Jun Qu, et al.Pageof 53